Formulation Challenges and Strategies to Develop Pediatric Dosage Forms

Area of Science:

• Pharmaceutical Sciences
• Pediatric Pharmacology
• Drug Delivery Systems

Background:

• Pediatric drug development faces unique challenges due to physiological and developmental differences in children compared to adults.
• Current reliance on adult formulations for pediatric use raises concerns regarding incorrect dosing, safety, and efficacy.
• Legislation like the Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA) promotes pediatric medication research and development.

Purpose of the Study:

• To review the challenges and opportunities in developing pediatric-specific dosage forms.
• To highlight the potential of buccal drug delivery as a pediatric-friendly alternative to oral formulations.
• To discuss clinical, physiological, formulation, and regulatory aspects of pediatric dosage form development.

Main Methods:

• Literature review focusing on pediatric drug formulation and delivery.
• Analysis of existing legislation impacting pediatric medication development.
• Discussion of clinical and physiological factors influencing pediatric dosage form design.
• Examination of formulation strategies and regulatory expectations.

Main Results:

• Oral and buccal dosage forms are identified as convenient options for pediatric patients.
• Buccal drug delivery presents a viable modality for creating pediatric-friendly dosage forms.
• Significant regulatory frameworks exist to encourage and guide pediatric drug development.
• Despite progress, a need persists for novel pediatric-specific formulations and dosage forms.

Conclusions:

• Pediatric drug formulation requires specialized approaches, with buccal delivery showing significant promise.
• Addressing clinical and physiological factors is crucial for successful pediatric dosage form development.
• Continued innovation in formulation and adherence to regulatory guidelines are essential for advancing pediatric pharmacotherapy.